Recent Advances in Multiple Myeloma: Insights from Experts at Levine Cancer Center, Duke University and UNC Lineberger Cancer Center - Episode 12

Bispecifics in Development for the Treatment of R/R MM

, , ,

Dr Tuchman highlights exciting bispecific agents in investigation for the treatment of relapsed/refractory multiple myeloma.